(CSTM) Constellium - Overview
Sector: Basic Materials | Industry: Aluminum | Exchange: NYSE (USA) | Market Cap: 3.806m USD | Total Return: 245.7% in 12m
EPS Trend: -10.6%
Qual. Beats: 2
Rev. Trend: -47.8%
Qual. Beats: 5
Constellium NV (NYSE:CSTM) designs, manufactures and sells rolled and extruded aluminium products across six end-markets-Aerospace, Packaging, Automotive, Commercial Transportation, General Industrial and Defence-through three operating segments: Packaging & Automotive Rolled Products, Aerospace & Transportation, and Automotive Structures & Industry.
In FY 2025 the company generated $4.2 billion of revenue, with an adjusted EBITDA margin of 11% and capital expenditures of $250 million, reflecting continued investment in high-growth battery-foil and lightweight-structure capabilities.
Key macro drivers include a 7% year-over-year rise in the global aluminium price index, accelerating EV battery-foil demand (projected to grow >15% CAGR through 2028), and a rebound in commercial aerospace orders that lifted aluminium-aircraft-part shipments by 12% in the last quarter.
For deeper insights, see ValueRay’s detailed analysis.
- Automotive demand for aluminum structures drives revenue growth
- Aerospace industry recovery boosts plate and sheet sales
- Aluminum price volatility impacts raw material costs
- Packaging segment performance tied to consumer spending
- Regulatory changes in automotive emissions affect product demand
| Net Income: 244.8m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.03 > 0.02 and ΔFCF/TA 5.18 > 1.0 |
| NWC/Revenue: 7.12% < 20% (prev 5.76%; Δ 1.36% < -1%) |
| CFO/TA 0.09 > 3% & CFO 497.6m > Net Income 244.8m |
| Net Debt (1.82b) to EBITDA (716.7m): 2.54 < 3 |
| Current Ratio: 1.29 > 1.5 & < 3 |
| Outstanding Shares: last quarter (141.9m) vs 12m ago -3.73% < -2% |
| Gross Margin: 9.65% > 18% (prev 0.13%; Δ 952.3% > 0.5%) |
| Asset Turnover: 145.9% > 50% (prev 142.2%; Δ 3.66% > 0%) |
| Interest Coverage Ratio: 4.56 > 6 (EBITDA TTM 716.7m / Interest Expense TTM 94.1m) |
| A: 0.10 (Total Current Assets 2.32b - Total Current Liabilities 1.80b) / Total Assets 5.35b |
| B: 0.07 (Retained Earnings 353.9m / Total Assets 5.35b) |
| C: 0.09 (EBIT TTM 429.4m / Avg Total Assets 5.04b) |
| D: 0.09 (Book Value of Equity 411.9m / Total Liabilities 4.38b) |
| Altman-Z'' Score: 1.53 = BB |
| DSRI: 1.36 (Receivables 722.8m/486.0m, Revenue 7.36b/6.73b) |
| GMI: 1.35 (GM 9.65% / 13.04%) |
| AQI: 0.80 (AQ_t 0.08 / AQ_t-1 0.10) |
| SGI: 1.09 (Revenue 7.36b / 6.73b) |
| TATA: -0.05 (NI 244.8m - CFO 497.6m) / TA 5.35b) |
| Beneish M-Score: -2.51 (Cap -4..+1) = A |
Over the past week, the price has changed by +19.77%, over one month by +4.86%, over three months by +41.35% and over the past year by +245.68%.
- StrongBuy: 3
- Buy: 2
- Hold: 0
- Sell: 0
- StrongSell: 0
| Wallstreet Target Price | 28.6 | 3.7% |
| Analysts Target Price | 28.6 | 3.7% |
P/E Forward = 8.1566
P/S = 0.4505
P/B = 3.8762
P/EG = 0.3974
Revenue TTM = 7.36b USD
EBIT TTM = 429.4m USD
EBITDA TTM = 716.7m USD
Long Term Debt = 1.91b USD (from longTermDebt, last quarter)
Short Term Debt = 39.0m USD (from shortTermDebt, last quarter)
Debt = 1.94b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 1.82b USD (from netDebt column, last quarter)
Enterprise Value = 5.63b USD (3.81b + Debt 1.94b - CCE 120.0m)
Interest Coverage Ratio = 4.56 (Ebit TTM 429.4m / Interest Expense TTM 94.1m)
EV/FCF = 34.55x (Enterprise Value 5.63b / FCF TTM 162.9m)
FCF Yield = 2.89% (FCF TTM 162.9m / Enterprise Value 5.63b)
FCF Margin = 2.22% (FCF TTM 162.9m / Revenue TTM 7.36b)
Net Margin = 3.33% (Net Income TTM 244.8m / Revenue TTM 7.36b)
Gross Margin = 9.65% ((Revenue TTM 7.36b - Cost of Revenue TTM 6.65b) / Revenue TTM)
Gross Margin QoQ = -11.73% (prev 14.50%)
Tobins Q-Ratio = 1.05 (Enterprise Value 5.63b / Total Assets 5.35b)
Interest Expense / Debt = 0.47% (Interest Expense 9.13m / Debt 1.94b)
Taxrate = 30.21% (36.6m / 121.3m)
NOPAT = 299.7m (EBIT 429.4m * (1 - 30.21%))
Current Ratio = 1.29 (Total Current Assets 2.32b / Total Current Liabilities 1.80b)
Debt / Equity = 2.04 (Debt 1.94b / totalStockholderEquity, last quarter 951.7m)
Debt / EBITDA = 2.54 (Net Debt 1.82b / EBITDA 716.7m)
Debt / FCF = 11.19 (Net Debt 1.82b / FCF TTM 162.9m)
Total Stockholder Equity = 830.4m (last 4 quarters mean from totalStockholderEquity)
RoA = 4.85% (Net Income 244.8m / Total Assets 5.35b)
RoE = 29.48% (Net Income TTM 244.8m / Total Stockholder Equity 830.4m)
RoCE = 15.70% (EBIT 429.4m / Capital Employed (Equity 830.4m + L.T.Debt 1.91b))
RoIC = 10.66% (NOPAT 299.7m / Invested Capital 2.81b)
WACC = 6.85% (E(3.81b)/V(5.75b) * Re(10.18%) + D(1.94b)/V(5.75b) * Rd(0.47%) * (1-Tc(0.30)))
Discount Rate = 10.18% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -2.47%
[DCF] Terminal Value 76.30% ; FCFF base≈162.9m ; Y1≈107.0m ; Y5≈48.9m
[DCF] Fair Price = N/A (negative equity: EV 1.23b - Net Debt 1.82b = -591.7m; debt exceeds intrinsic value)
EPS Correlation: -10.60 | EPS CAGR: -14.18% | SUE: 1.69 | # QB: 2
Revenue Correlation: -47.79 | Revenue CAGR: -14.34% | SUE: 3.32 | # QB: 5
EPS next Quarter (2026-06-30): EPS=0.47 | Chg7d=+0.124 | Chg30d=+0.124 | Revisions Net=+0 | Analysts=1
EPS current Year (2026-12-31): EPS=1.72 | Chg7d=+0.011 | Chg30d=+0.011 | Revisions Net=+0 | Growth EPS=+6.1% | Growth Revenue=+14.4%
EPS next Year (2027-12-31): EPS=1.88 | Chg7d=+0.299 | Chg30d=+0.299 | Revisions Net=+1 | Growth EPS=+11.2% | Growth Revenue=+0.8%
[Analyst] Revisions Ratio: +0.00 (1 Up / 1 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 3.2% (Discount Rate 10.2% - Earnings Yield 7.0%)
[Growth] Growth Spread = +12.5% (Analyst 15.8% - Implied 3.2%)